George Karpouzas, MD (he/him/his)

Harbor-UCLA Medical Center
Torrance, CA, United States

Professor of Medicine, David Geffen School of Medicine, UCLA
Chief, Division of Rheumatology, Harbor-UCLA Medical Center
The Lundquist Institute for Medical Innovation

Presentation(s):

• 0390: Statins Influence the Relationship Between ATP-binding Cassette Transporter A1 (ABCA1)-mediated Cholesterol Efflux and Coronary Atherosclerosis in Rheumatoid Arthritis

  Sunday, November 12, 2023
  9:00 AM - 11:00 AM PT

  Disclosure information not submitted.

• 0391: Biologic Use Regulates the Impact of Inflammation on Ischemic Cardiovascular Risk in Rheumatoid Arthritis

  Sunday, November 12, 2023
  9:00 AM - 11:00 AM PT

  Disclosure information not submitted.

• 1305: Variations in Macrophage Cholesterol Loading over Time Are Linked to Dynamic Changes in Coronary Atherosclerotic Plaque in Rheumatoid Arthritis

  Monday, November 13, 2023
  9:00 AM - 11:00 AM PT

  Disclosure information not submitted.

• 1306: Statin Use Attenuates the Impact of Systemic Inflammation on Ischemic Cardiovascular Risk in Patients with Rheumatoid Arthritis

  Monday, November 13, 2023
  9:00 AM - 11:00 AM PT

  Disclosure information not submitted.

• 1627: Methotrexate Use Associates with Ischemic Cardiovascular Risk Reduction in Males but Not Females with Rheumatoid Arthritis

  Monday, November 13, 2023
  2:00 PM - 2:10 PM PT

  Disclosure information not submitted.

• 2103: Inflammation and Immunomodulatory Therapies Influence the Relationship Between ATP-binding Cassette Transporter A1 (ABCA1)-mediated Cholesterol Efflux and Coronary Atherosclerosis in Rheumatoid Arthritis

  Tuesday, November 14, 2023
  9:00 AM - 11:00 AM PT

  Disclosure information not submitted.